HCP Live (12/15, Smith) reported the FDA “announced that it has approved of newly-required measures related to safety labels for opioid pain medicines, part of a move to support patients’ ability to make better-informed decisions about opioid use.” Announced Friday, “the FDA’s decision is considered to be part of the agency’s Overdose Prevention Framework. The framework outlines the FDA’s commitment to taking actions to prevent overdoses and decrease drug-related fatalities.”
Related Links:
— “FDA Announces Approval of Opioid Pain Medication Safety Labeling Changes,” Tim Smith, HCP Live, December 15, 2023